203 related articles for article (PubMed ID: 8042557)
1. High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
Hildebrandt G; Scheidhauer K; Luyken C; Schicha H; Klug N; Dahms P; Krisch B
Acta Neurochir (Wien); 1994; 126(2-4):63-71. PubMed ID: 8042557
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.
Scheidhauer K; Hildebrandt G; Luyken C; Schomäcker K; Klug N; Schicha H
Horm Metab Res Suppl; 1993; 27():59-62. PubMed ID: 8330874
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of somatostatin receptor scintigraphy in patients with skull base tumours.
Luyken C; Hildebrandt G; Krisch B; Scheidhauer K; Klug N
Acta Neurochir Suppl; 1996; 65():102-4. PubMed ID: 8738508
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy.
Barth A; Haldemann AR; Reubi JC; Godoy N; Rösler H; Kinser JA; Seiler RW
Acta Neurochir (Wien); 1996; 138(10):1179-85. PubMed ID: 8955437
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-D-Phe-1-octreotide.
Maini CL; Tofani A; Sciuto R; Carapella C; Cioffi R; Crecco M
Nucl Med Commun; 1993 Jul; 14(7):550-8. PubMed ID: 8355914
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma.
Klutmann S; Bohuslavizki KH; Brenner W; Behnke A; Tietje N; Kröger S; Hugo HH; Mehdorn HM; Clausen M; Henze E
J Nucl Med; 1998 Nov; 39(11):1913-7. PubMed ID: 9829583
[TBL] [Abstract][Full Text] [Related]
7. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
[TBL] [Abstract][Full Text] [Related]
8. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
9. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
Nathoo N; Ugokwe K; Chang AS; Li L; Ross J; Suh JH; Vogelbaum MA; Barnett GH
J Neurooncol; 2007 Jan; 81(2):167-74. PubMed ID: 16850106
[TBL] [Abstract][Full Text] [Related]
10. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
Seifert JK; Görges R; Bockisch A; Junginger T
Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
[TBL] [Abstract][Full Text] [Related]
11. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
Westlin JE; Janson ET; Arnberg H; Ahlström H; Oberg K; Nilsson S
Acta Oncol; 1993; 32(7-8):783-6. PubMed ID: 8305227
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma.
Hellwig D; Samnick S; Reif J; Romeike BF; Reith W; Moringlane JR; Kirsch CM
Clin Nucl Med; 2002 Nov; 27(11):781-4. PubMed ID: 12394124
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor imaging: current status and future perspectives.
Bohuslavizki KH
J Nucl Med; 2001 Jul; 42(7):1057-8. PubMed ID: 11438628
[No Abstract] [Full Text] [Related]
15. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.
Alexandru D; Glantz MJ; Kim L; Chamberlain MC; Bota DA
Cancer; 2011 Oct; 117(19):4506-11. PubMed ID: 21446045
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
Haldemann AR; Rösler H; Barth A; Waser B; Geiger L; Godoy N; Markwalder RV; Seiler RW; Sulzer M; Reubi JC
J Nucl Med; 1995 Mar; 36(3):403-10. PubMed ID: 7884502
[TBL] [Abstract][Full Text] [Related]
17. 111Indium-octreotide brain scintigraphy: a prognostic factor in skull base meningiomas treated with gamma knife radiosurgery.
Nicolato A
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):26-32. PubMed ID: 15195001
[TBL] [Abstract][Full Text] [Related]
18. 111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas.
Luyken C; Hildebrandt G; Scheidhauer K; Krisch B; Schicha H; Klug N
Acta Neurochir (Wien); 1994; 127(1-2):60-4. PubMed ID: 7942184
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Wangberg B; Forssell-Aronsson E; Tisell LE; Nilsson O; Fjalling M; Ahlman H
Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378
[TBL] [Abstract][Full Text] [Related]
20. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
Modlin IM; Cornelius E; Lawton GP
Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]